Integrative Therapeutics | Vasophil Sour Apple Flavored | 30 Sachets

Integrative Therapeutics

$ 57.00 

Vasophil Sour Apple Flavored | 30 Sachets:

Dietary Supplement!


L-Arginine and L-Citrulline Combination for Nitric Oxide Synthesis!

 

Vasophil is a combination of free form amino acids designed to support nitric oxide (NO) production and healthy peripheral circulation. Unlike many other nitric oxide supplements, Vasophil contains both arginine and citrulline to support healthy cardiovascular function, vasodilation, blood flow, and sexual function.


Arginine is involved in immune function, ammonia metabolism, and the secretion of hormones and is perhaps best known as a biochemical precursor to nitric oxide. Citrulline acts as an arginine precursor for NO synthesis1 and plays an important part in NO metabolism and regulation.2 as with other amino acids, the effective dose range for arginine and citrulline is 3 grams or more of each.

 

Vasophil Features:

  • 3 grams of free-form arginine and 3 grams of free-form citrulline
  • Great-tasting, sour apple-flavored drink mix
  • Convenient single serving packets

Supplement Facts:

Serving Size: 1 Sachet

Servings per Container: 30

Quantity per Container: 30 Sachets

Amount Per Serving:

 

Ingredient Amount % Daily Value
Calories 25
L-Arginine‡ 3 g **
L-Citrulline‡ 3 g **


Directions and/or Dosage:

Mix the contents of 1 sachet in 6-8 oz. of cold water or juice daily, or as recommended by your healthcare professional.

 

Other Ingredients:
Malic acid, citric acid, natural flavors, silicon dioxide. 

 

Does Not Contain:

  • Artificial coloring
  • Artificial flavoring
  • Corn
  • Dairy products
  • Gluten
  • Ingredients of animal origin
  • Preservatives
  • Salt
  • Soy
  • Sugar
  • Wheat
  • Yeast

Notes:
If pregnant, nursing, or taking prescription drugs, or if you have a history of genital or oral herpes, asthma, or cancer, consult your healthcare professional prior to use.

 

1: Wu G. J Nutr 1998; 128:1249-52.
2: Romero MJ, Platt DH, Caldwell RB, Caldwell RW. Cardiovasc Drug Rev 2006; 24:275-90.